Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Operating Expenses (2016 - 2026)

Ekso Bionics Holdings has reported Other Operating Expenses over the past 14 years, most recently at $2.4 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 29.72% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.2 million, a 2.11% decrease, with the full-year FY2025 number at $7.2 million, down 2.11% from a year prior.
  • Other Operating Expenses reached $2.4 million in Q4 2025 per EKSO's latest filing, up from $1.3 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $2.4 million in Q4 2025, with the low at $1.3 million in Q3 2025.
  • The 5-year median for Other Operating Expenses is $1.8 million (2022), against an average of $1.9 million.
  • Peak YoY movement for Other Operating Expenses: fell 28.85% in 2021, then rose 29.72% in 2025.
  • Tracing EKSO's Other Operating Expenses over 5 years: stood at $2.0 million in 2021, then dropped by 4.66% to $1.9 million in 2022, then grew by 1.95% to $2.0 million in 2023, then decreased by 4.99% to $1.9 million in 2024, then grew by 29.72% to $2.4 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $2.4 million, $1.3 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.